Search - tctmd.com

Displaying 641 - 660 of 821

Sort: Relevancy | Date

News Industry News

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

July 02, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Con o Sin Cefalea, las Auras Secundarias al FOP Tienen la Misma Causa

June 19, 2012

News Daily News

FDA Panel Vote on TAVR Expansion Buoys Advocates

June 19, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Daily News

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Jason Kahn

June 08, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Stress Echo Appears Overused in Asymptomatic Patients after Revascularization

May 24, 2012

News Industry News

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

May 18, 2012

News Conference News EuroPCR 2012

Thrombectomy Results Underwhelming in AMI Patients

Jason Kahn

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

News Industry News

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

May 15, 2012

News Industry News

Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System

May 14, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

News Daily News

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

April 30, 2012

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

April 23, 2012

Advertisement

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Con o Sin Cefalea, las Auras Secundarias al FOP Tienen la Misma Causa

FDA Panel Vote on TAVR Expansion Buoys Advocates

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Watchman Works Just as Well Without Warfarin-Protected Transition

Stress Echo Appears Overused in Asymptomatic Patients after Revascularization

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

Thrombectomy Results Underwhelming in AMI Patients

Strong Showing for Bioabsorbable-Scaffold DES

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

CMS Agrees to Cover TAVR for FDA-Approved Use

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content